[{"bbox": [88, 94, 372, 134], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [88, 168, 1563, 364], "category": "Text", "text": "The market is projected to expand steadily, reaching USD 241 million by 2033. This future growth reflects a broader shift in India's healthcare approach, with increasing emphasis on early detection, at-home diagnostics, and point-of-care solutions. Factors such as improved healthcare infrastructure, growing awareness about lifestyle and infectious diseases, and government initiatives are expected to support this consistent rise. The forecast suggests the market will evolve from a reactive, crisis-driven sector to a more integrated part of everyday healthcare, particularly in urban and semi-urban settings, with potential to grow further as accessibility improves in rural areas."}, {"bbox": [88, 391, 496, 429], "category": "Section-header", "text": "## Market Segmentation by Product"}, {"bbox": [90, 456, 521, 491], "category": "Caption", "text": "Table 4: Description of Product Type"}, {"bbox": [90, 486, 1561, 996], "category": "Table", "text": "<table><thead><tr><td>Sr No.</td><td>Product Type</td><td>Description</td></tr></thead><tbody><tr><td>1</td><td>Reagents & Kits</td><td>This segment holds the largest market share as reagents and kits are essential consumables used in diagnostic tests across various applications, including immunoassays, molecular diagnostics, and clinical chemistry. The increasing prevalence of diseases and growing adoption of point-of-care testing are driving demand in this category.</td></tr><tr><td>2</td><td>Instruments</td><td>Diagnostic instruments, such as analyser's and automated testing machines, are critical for performing tests with high accuracy and efficiency. With advancements in technology and automation, this segment is witnessing steady growth, particularly in hospitals, laboratories, and diagnostic centres.</td></tr><tr><td>3</td><td>Services</td><td>The integration of digital health solutions, artificial intelligence, and data analytics in diagnostics has led to the growth of software solutions for result interpretation, lab automation, and remote diagnostics. Additionally, maintenance and support services for IVD instruments contribute to this segment's expansion.</td></tr></tbody></table>"}, {"bbox": [99, 1025, 939, 1065], "category": "Caption", "text": "Chart 12: India In-Vitro Diagnostics Market Landscape - by Product Type"}, {"bbox": [101, 1060, 1358, 1684], "category": "Picture"}, {"bbox": [90, 1730, 1563, 1957], "category": "Text", "text": "Among the key segments, reagents and kits hold the largest share, contributing significantly to overall market growth. This segment grew from 836 Million USD in CY19 to 999 Million USD in CY24 and is projected to reach 1,925 Million USD by CY30, driven by increasing diagnostic needs due to growing geriatric population and technological advancements. Instruments, which are vital for performing various diagnostic tests, have also seen steady growth, rising from 291 Million USD in CY19 to 375 Million USD in CY24, with an expected market size of 776 Million USD by CY30. Although smaller in size, the services segment is essential for supporting the diagnostic ecosystem, growing from 110 million USD in CY19 to 138 million USD in CY24 and anticipated to reach 277 million USD by CY30."}, {"bbox": [90, 1985, 704, 2023], "category": "Caption", "text": "Chart 2: Market Share by Product Type - CY 2024"}]